Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD)

This study has been terminated.
(European reports of liver toxicity from kava meant that the study had to stop)
Sponsor:
Information provided by (Responsible Party):
National Center for Complementary and Alternative Medicine (NCCAM)
ClinicalTrials.gov Identifier:
NCT00083980
First received: June 4, 2004
Last updated: October 18, 2012
Last verified: August 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2004
  Primary Completion Date: June 2004 (Final data collection date for primary outcome measure)